Myocardial infarction in patients with severe beta thalassaemia: a case series

Anuja Premawardhena1, Shamila De Silva2, Megha Rajapaksha3

  • 1Department of Medicine: Faculty of Medicine, University of Kelaniya, Kelaniya, Sri Lanka. premawa@kln.ac.lk.

Insights

Cardiac disease is a major concern in thalassemia patients. Acute coronary syndromes, including myocardial infarction, are rarely reported but occurred in three patients, with unclear causes.

Area of Science:

  • Cardiology
  • Hematology
  • Internal Medicine

Background:

  • Cardiac disease is a leading cause of morbidity and mortality in thalassemia patients, especially those with thalassemia major.
  • Myocardial infarction and coronary artery disease are seldom reported in this population.
  • This study examines rare cases of acute coronary syndrome in patients with thalassemia syndromes.

Purpose of the Study:

  • To investigate the presentation and potential etiology of acute coronary syndrome (ACS) in patients with thalassemia.
  • To highlight the diagnostic and therapeutic challenges in managing ACS in this unique patient group.

Main Methods:

  • Case series of three adult patients with distinct thalassemia syndromes presenting with ACS.
  • Detailed review of clinical presentation, transfusion history, cardiac investigations including coronary angiography, and management.
  • Analysis of etiological factors, distinguishing between atherosclerotic and non-atherosclerotic causes.

Main Results:

  • Two heavily transfused patients experienced ST-elevation myocardial infarctions (STEMI); one minimally transfused patient had unstable angina.
  • Coronary angiography revealed normal findings in two patients; one STEMI patient had a 50% plaque.
  • All patients were managed with standard ACS protocols, despite a presumed non-atherogenic etiology.

Conclusions:

  • The precise cause of ACS in these thalassemia patients remains undetermined.
  • The optimal use of thrombolytic therapy, primary percutaneous coronary intervention, antiplatelet agents, and high-dose statins in this subgroup requires further clarification.
Abstract

Related Concept Videos

Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
14
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
11
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
16
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
20
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
45
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
21